These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30125050)

  • 1. Performance evaluation study of ID RHD XT, a new genotyping assay for the detection of high-prevalence RhD negative and weak D types.
    Molano A; Apraiz I; España P; Azkarate M; Vesga MÁ; Rubia M; Piedrabuena M; Puente F; Veldhuisen B; van der Schoot E; Tejedor D; López M
    Vox Sang; 2018 Oct; 113(7):694-700. PubMed ID: 30125050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice.
    Londero D; Monge J; Hellberg A
    Vox Sang; 2020 Apr; 115(3):241-248. PubMed ID: 31912520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of red blood cell and platelet antigen genotyping platforms (ID CORE XT/ID HPA XT) in routine clinical practice.
    Finning K; Bhandari R; Sellers F; Revelli N; Villa MA; Muñiz-Díaz E; Nogués N
    Blood Transfus; 2016 Mar; 14(2):160-7. PubMed ID: 26674823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles.
    Vege S; Sprogøe U; Lomas-Francis C; Jakobsen MA; Antonsen B; Aeschlimann J; Yazer M; Westhoff CM
    Transfusion; 2021 Jan; 61(1):256-265. PubMed ID: 32975828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform.
    López M; Apraiz I; Rubia M; Piedrabuena M; Azkarate M; Veldhuisen B; Vesga MÁ; Van Der Schoot E; Puente F; Tejedor D
    Blood Transfus; 2018 Feb; 16(2):193-199. PubMed ID: 27893355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying obstetrics patients in whom RHD genotyping can be used to assess risk of D alloimmunization.
    Horn TN; Keller J; Keller MA; Klinger L
    Immunohematology; 2020 Dec; 36(4):146-151. PubMed ID: 33544620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance and costs of RHD genotyping in women with a weak D phenotype.
    Laget L; Izard C; Durieux-Roussel E; Gouvitsos J; Dettori I; Chiaroni J; Ferrera-Tourenc V
    Transfus Clin Biol; 2019 Feb; 26(1):27-31. PubMed ID: 29866395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance of two polymerase chain reaction-based blood group genotyping platforms for patients with sickle cell disease.
    Sheppard CA; Bolen NL; Meny G; Kalvelage M; Ochoa-Garay G
    Immunohematology; 2020 Dec; 36(4):123-128. PubMed ID: 33544616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.
    McGowan EC; Lopez GH; Knauth CM; Liew YW; Condon JA; Ramadi L; Parsons K; Turner EM; Flower RL; Hyland CA
    Vox Sang; 2017 Apr; 112(3):279-287. PubMed ID: 28220510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a blood group genotyping platform (BLOODchip(®) Reference) in Japanese samples.
    Tanaka M; Kamada I; Takahashi J; Hirayama F; Tani Y
    Transfus Med; 2014 Feb; 24(1):39-44. PubMed ID: 24152224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHD genotyping of serologic RhD-negative blood donors in a hospital-based blood donor center.
    Perez-Alvarez I; Hayes C; Hailemariam T; Shin E; Hutchinson T; Klapper E
    Transfusion; 2019 Jul; 59(7):2422-2428. PubMed ID: 31059639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHD genotyping of serological weak D phenotypes in the Iranian blood donors and patients.
    Oodi A; Daneshvar Z; Goudarzi S; Amirizadeh N
    Transfus Apher Sci; 2020 Oct; 59(5):102870. PubMed ID: 32660892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes.
    Cruz BR; Chiba AK; Moritz E; Bordin JO
    Transfus Med; 2012 Apr; 22(2):84-9. PubMed ID: 22211984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen.
    Chun S; Kim H; Yun JW; Yu H; Seo JY; Cho D
    Transfus Apher Sci; 2020 Aug; 59(4):102807. PubMed ID: 32423605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of methods for the detection of the r'(s) haplotype.
    Moulds JM; Noumsi GT; Billingsley KL
    Transfusion; 2015 Jun; 55(6 Pt 2):1418-22. PubMed ID: 25496603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RHCE variants inherited with altered RHD alleles in Brazilian blood donors.
    Prisco Arnoni C; Guilhem Muniz J; de Paula Vendrame TA; de Medeiros Person R; Roche Moreira Latini F; Castilho L
    Transfus Med; 2016 Aug; 26(4):285-90. PubMed ID: 27111588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D variants in the population of D-negative blood donors in the north-eastern region of Croatia.
    Safic Stanic H; Dogic V; Herceg I; Jagnjic S; Bingulac-Popovic J; Babic I; Corusic A; Jukic I
    Transfus Med; 2021 Feb; 31(1):43-47. PubMed ID: 33034130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles.
    Fichou Y; Le Maréchal C; Jamet D; Bryckaert L; Ka C; Audrézet MP; Le Gac G; Dupont I; Chen JM; Férec C
    Transfusion; 2013 Aug; 53(8):1821-8. PubMed ID: 23228153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.